Franklin Resources Inc Ultragenyx Pharmaceutical Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

A detailed history of Franklin Resources Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 293,894 shares of RARE stock, worth $17.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
293,894
Previous 215,916 36.11%
Holding current value
$17.3 Million
Previous $10.1 Million 19.82%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$37.42 - $51.61 $2.92 Million - $4.02 Million
77,978 Added 36.11%
293,894 $12.1 Million
Q1 2024

May 13, 2024
BUY
$43.02 - $53.69 $50,677 - $63,246
1,178 Added 0.55%
215,916 $10.1 Million
Q4 2023

Feb 09, 2024
BUY
$31.73 - $49.19 $797,819 - $1.24 Million
25,144 Added 13.26%
214,738 $10.3 Million
Q3 2023

Nov 13, 2023
BUY
$34.92 - $46.66 $348,361 - $465,480
9,976 Added 5.55%
189,594 $6.76 Million
Q2 2023

Aug 11, 2023
BUY
$37.35 - $52.15 $4,706 - $6,570
126 Added 0.07%
179,618 $8.29 Million
Q1 2023

May 12, 2023
SELL
$36.99 - $48.71 $59,184 - $77,936
-1,600 Reduced 0.88%
179,492 $7.2 Million
Q4 2022

Feb 10, 2023
BUY
$33.72 - $46.33 $92,021 - $126,434
2,729 Added 1.53%
181,092 $8.39 Million
Q3 2022

Nov 14, 2022
SELL
$39.96 - $66.14 $33,326 - $55,160
-834 Reduced 0.47%
178,363 $7.39 Million
Q1 2022

May 13, 2022
SELL
$62.2 - $84.4 $870 - $1,181
-14 Reduced 0.01%
179,197 $13 Million
Q4 2021

Feb 11, 2022
SELL
$73.71 - $87.86 $1.71 Million - $2.04 Million
-23,250 Reduced 11.48%
179,211 $15.1 Million
Q3 2021

Nov 12, 2021
BUY
$77.92 - $102.4 $5,921 - $7,782
76 Added 0.04%
202,461 $18.3 Million
Q2 2021

Aug 13, 2021
SELL
$92.19 - $115.71 $3,871 - $4,859
-42 Reduced 0.02%
202,385 $19.3 Million
Q1 2021

May 13, 2021
SELL
$106.9 - $167.73 $5.52 Million - $8.66 Million
-51,651 Reduced 20.33%
202,427 $23 Million
Q4 2020

Feb 10, 2021
SELL
$84.4 - $177.39 $10.9 Million - $22.8 Million
-128,749 Reduced 33.63%
254,078 $35.2 Million
Q3 2020

Nov 12, 2020
BUY
$72.98 - $90.0 $25,834 - $31,860
354 Added 0.09%
382,827 $31.5 Million
Q1 2020

May 13, 2020
BUY
$33.8 - $62.9 $399,617 - $743,666
11,823 Added 3.19%
382,473 $17 Million
Q4 2019

Feb 12, 2020
BUY
$36.08 - $45.83 $8.13 Million - $10.3 Million
225,200 Added 154.83%
370,650 $15.8 Million
Q3 2019

Nov 14, 2019
BUY
$42.5 - $63.11 $6.18 Million - $9.18 Million
145,450 New
145,450 $6.22 Million

Others Institutions Holding RARE

# of Institutions
287
Shares Held
88.1M
Call Options Held
505K
Put Options Held
198K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $4.12B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email